Jefferies & Company has downgraded Metabolix (NASDAQ:
MBLX) from Buy to Hold and has lowered the price target from $9 to $4.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
